HIF1A and ovarian carcinoma: In order to validate this association, we monitored dynamic intracellular metabolic changes upon HIF-1A mRNA degradation (i.e., siRNA knockdown) in IGROV1 ovarian cancer cells, exhibiting an average basal level of HIF-1A activity (Supplementary Fig. 5).